• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配体和细胞依赖性决定因素对内源性阿片受体(DOR)激动剂内化和 cAMP 调节的影响。

Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists.

出版信息

Cell Mol Life Sci. 2014 Apr;71(8):1529-46. doi: 10.1007/s00018-013-1461-7.

DOI:10.1007/s00018-013-1461-7
PMID:24022593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3952036/
Abstract

Signaling bias refers to G protein-coupled receptor ligand ability to preferentially activate one type of signal over another. Bias to evoke signaling as opposed to sequestration has been proposed as a predictor of opioid ligand potential for generating tolerance. Here we measured whether delta opioid receptor agonists preferentially inhibited cyclase activity over internalization in HEK cells. Efficacy (τ) and affinity (KA) values were estimated from functional data and bias was calculated from efficiency coefficients (log τ/KA). This approach better represented the data as compared to alternative methods that estimate bias exclusively from τ values. Log (τ/KA) coefficients indicated that SNC-80 and UFP-512 promoted cyclase inhibition more efficiently than DOR internalization as compared to DPDPE (bias factor for SNC-80: 50 and for UFP-512: 132). Molecular determinants of internalization were different in HEK293 cells and neurons with βarrs contributing to internalization in both cell types, while PKC and GRK2 activities were only involved in neurons. Rank orders of ligand ability to engage different internalization mechanisms in neurons were compared to rank order of E max values for cyclase assays in HEK cells. Comparison revealed a significant reversal in rank order for cyclase E max values and βarr-dependent internalization in neurons, indicating that these responses were ligand-specific. Despite this evidence, and because kinases involved in internalization were not the same across cellular backgrounds, it is not possible to assert if the magnitude and nature of bias revealed by rank orders of maximal responses is the same as the one measured in HEK cells.

摘要

信号偏倚是指 G 蛋白偶联受体配体优先激活一种信号而不是另一种信号的能力。与隔离相比,诱发信号的偏倚被认为是预测阿片类配体产生耐受的潜在因素。在这里,我们测量了δ阿片受体激动剂是否优先抑制环化酶活性而不是在 HEK 细胞中内化。从功能数据中估计了效力(τ)和亲和力(KA)值,并从效率系数(log τ/KA)计算了偏倚。与仅从τ值估计偏倚的替代方法相比,这种方法更好地代表了数据。Log(τ/KA)系数表明,与 DPDPE 相比,SNC-80 和 UFP-512 更有效地促进环化酶抑制,而不是 DOR 内化(SNC-80 的偏倚因子:50,UFP-512:132)。在 HEK293 细胞和神经元中,内化的分子决定因素不同,βarrs 有助于两种细胞类型的内化,而 PKC 和 GRK2 活性仅参与神经元。将配体在神经元中参与不同内化机制的能力的排序与环化酶测定中 HEK 细胞的 E max 值的排序进行比较。比较表明,环化酶 E max 值和神经元中βarr 依赖性内化的排序发生了显著逆转,表明这些反应是配体特异性的。尽管有这些证据,而且由于参与内化的激酶在不同的细胞背景下并不相同,因此无法断言通过最大反应排序揭示的偏倚幅度和性质是否与在 HEK 细胞中测量的相同。

相似文献

1
Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists.配体和细胞依赖性决定因素对内源性阿片受体(DOR)激动剂内化和 cAMP 调节的影响。
Cell Mol Life Sci. 2014 Apr;71(8):1529-46. doi: 10.1007/s00018-013-1461-7.
2
Endocytic profiles of δ-opioid receptor ligands determine the duration of rapid but not sustained cAMP responses.δ-阿片受体配体的内吞特征决定了快速但非持续的 cAMP 反应的持续时间。
Mol Pharmacol. 2014 Jan;85(1):148-61. doi: 10.1124/mol.113.089003. Epub 2013 Oct 30.
3
Different kinases desensitize the human delta-opioid receptor (hDOP-R) in the neuroblastoma cell line SK-N-BE upon peptidic and alkaloid agonists.在神经母细胞瘤细胞系SK-N-BE中,不同的激酶会使人类δ-阿片受体(hDOP-R)对肽类和生物碱类激动剂产生脱敏作用。
Cell Signal. 2008 Jun;20(6):1209-20. doi: 10.1016/j.cellsig.2008.02.010. Epub 2008 Feb 19.
4
Post-endocytic fates of delta-opioid receptor are regulated by GRK2-mediated receptor phosphorylation and distinct beta-arrestin isoforms.δ-阿片受体的内吞后命运受GRK2介导的受体磷酸化和不同β-抑制蛋白亚型的调控。
J Neurochem. 2008 Jul;106(2):781-92. doi: 10.1111/j.1471-4159.2008.05431.x. Epub 2008 Apr 17.
5
G protein independent phosphorylation and internalization of the delta-opioid receptor.δ-阿片受体的G蛋白非依赖性磷酸化与内化
J Neurochem. 2009 Jun;109(5):1526-35. doi: 10.1111/j.1471-4159.2009.06082.x. Epub 2009 Apr 1.
6
Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization.Src在δ-阿片受体脱敏和内化的配体特异性调节中的作用。
J Neurochem. 2009 Jan;108(1):102-14. doi: 10.1111/j.1471-4159.2008.05740.x. Epub 2008 Nov 10.
7
Ligand-directed trafficking of the δ-opioid receptor in vivo: two paths toward analgesic tolerance.体内 δ-阿片受体配体导向的贩运:两种走向镇痛耐受的途径。
J Neurosci. 2010 Dec 8;30(49):16459-68. doi: 10.1523/JNEUROSCI.3748-10.2010.
8
The molecular mechanisms of cellular tolerance to delta-opioid agonists. A minireview.细胞对δ阿片受体激动剂耐受性的分子机制。一篇综述。
Acta Biol Hung. 2003;54(2):203-18. doi: 10.1556/ABiol.54.2003.2.9.
9
Differential association of receptor-Gβγ complexes with β-arrestin2 determines recycling bias and potential for tolerance of δ opioid receptor agonists.受体-Gβγ 复合物与β-arrestin2 的差异关联决定了 δ 阿片受体激动剂的回收偏向和潜在的耐受性。
J Neurosci. 2012 Apr 4;32(14):4827-40. doi: 10.1523/JNEUROSCI.3734-11.2012.
10
Desensitization of endogenously expressed delta-opioid receptors: no evidence for involvement of G protein-coupled receptor kinase 2.内源性表达的δ-阿片受体脱敏:无证据表明G蛋白偶联受体激酶2参与其中。
Eur J Pharmacol. 2001 Nov 16;431(2):133-41. doi: 10.1016/s0014-2999(01)01360-7.

引用本文的文献

1
Dipyanone, a new methadone-like synthetic opioid: In vitro and in vivo human metabolism and pharmacological profiling.二吡酮,一种新型美沙酮类合成阿片类药物:体外和体内人体代谢及药理学分析。
Arch Toxicol. 2025 Apr 29. doi: 10.1007/s00204-025-04023-1.
2
Opioid receptors signaling network.阿片受体信号网络。
J Cell Commun Signal. 2022 Sep;16(3):475-483. doi: 10.1007/s12079-021-00653-z. Epub 2021 Nov 1.
3
Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation.综合信号谱揭示了δ-阿片受体激动剂意想不到的功能选择性,并有助于鉴定具有诱导环化酶超激活最大潜力的配体。
ACS Pharmacol Transl Sci. 2021 Sep 9;4(5):1483-1498. doi: 10.1021/acsptsci.1c00019. eCollection 2021 Oct 8.
4
Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors.阿片受体偏向药理学综述:偏向性配体与偏向因子
RSC Med Chem. 2021 Apr 21;12(6):828-870. doi: 10.1039/d1md00041a. eCollection 2021 Jun 23.
5
Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes.内源性μ和δ阿片受体的异源二聚化诱导配体选择性共靶向溶酶体。
Molecules. 2020 Sep 30;25(19):4493. doi: 10.3390/molecules25194493.
6
Vitamin D and Its Potential Interplay With Pain Signaling Pathways.维生素 D 及其与疼痛信号通路的潜在相互作用。
Front Immunol. 2020 May 28;11:820. doi: 10.3389/fimmu.2020.00820. eCollection 2020.
7
Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies.激动剂诱导的 δ 阿片受体磷酸化条码及激活后信号的差异通过磷酸化位点特异性抗体揭示。
Sci Rep. 2020 May 22;10(1):8585. doi: 10.1038/s41598-020-65589-7.
8
Ligand-specific recycling profiles determine distinct potential for chronic analgesic tolerance of delta-opioid receptor (DOPr) agonists.配体特异性回收谱决定了 δ 阿片受体 (DOPr) 激动剂慢性镇痛耐受的潜在差异。
J Cell Mol Med. 2020 May;24(10):5718-5730. doi: 10.1111/jcmm.15234. Epub 2020 Apr 12.
9
Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response.探索使用无监督聚类将 GPCR 配体的信号转导谱与临床反应相关联。
Nat Commun. 2019 Sep 9;10(1):4075. doi: 10.1038/s41467-019-11875-6.
10
The δ-opioid receptor positive allosteric modulator BMS 986187 is a G-protein-biased allosteric agonist.δ 型阿片受体正变构调节剂 BMS 986187 是一种 G 蛋白偏向性变构激动剂。
Br J Pharmacol. 2019 Jun;176(11):1649-1663. doi: 10.1111/bph.14602. Epub 2019 Apr 14.

本文引用的文献

1
Signalling bias in new drug discovery: detection, quantification and therapeutic impact.新药发现中的信号偏倚:检测、定量和治疗影响。
Nat Rev Drug Discov. 2013 Mar;12(3):205-16. doi: 10.1038/nrd3954. Epub 2012 Feb 15.
2
Stimulus bias provides evidence for conformational constraints in the structure of a G protein-coupled receptor.刺激偏倚为 G 蛋白偶联受体结构中的构象约束提供了证据。
J Biol Chem. 2012 Oct 26;287(44):37066-77. doi: 10.1074/jbc.M112.408534. Epub 2012 Sep 10.
3
A simple method for quantifying functional selectivity and agonist bias.一种量化功能选择性和激动剂偏向性的简单方法。
ACS Chem Neurosci. 2012 Mar 21;3(3):193-203. doi: 10.1021/cn200111m. Epub 2011 Dec 20.
4
δ-Opioid mechanisms for ADL5747 and ADL5859 effects in mice: analgesia, locomotion, and receptor internalization.δ-阿片样物质机制在 ADL5747 和 ADL5859 对小鼠行为作用的影响:镇痛、运动和受体内化。
J Pharmacol Exp Ther. 2012 Sep;342(3):799-807. doi: 10.1124/jpet.111.188987. Epub 2012 Jun 13.
5
Endomorphin-2: a biased agonist at the μ-opioid receptor.内吗啡肽-2:μ 阿片受体的偏激动剂。
Mol Pharmacol. 2012 Aug;82(2):178-88. doi: 10.1124/mol.112.078659. Epub 2012 May 2.
6
Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.血管紧张素类似物揭示的差异β-arrestin 依赖构象信号和细胞反应。
Sci Signal. 2012 Apr 24;5(221):ra33. doi: 10.1126/scisignal.2002522.
7
Differential association of receptor-Gβγ complexes with β-arrestin2 determines recycling bias and potential for tolerance of δ opioid receptor agonists.受体-Gβγ 复合物与β-arrestin2 的差异关联决定了 δ 阿片受体激动剂的回收偏向和潜在的耐受性。
J Neurosci. 2012 Apr 4;32(14):4827-40. doi: 10.1523/JNEUROSCI.3734-11.2012.
8
Biased signalling and allosteric machines: new vistas and challenges for drug discovery.偏向信号和别构机器:药物发现的新视野和新挑战。
Br J Pharmacol. 2012 Mar;165(6):1659-1669. doi: 10.1111/j.1476-5381.2011.01749.x.
9
The delta opioid receptor: an evolving target for the treatment of brain disorders.德尔塔阿片受体:治疗脑部疾病的新兴靶点。
Trends Pharmacol Sci. 2011 Oct;32(10):581-90. doi: 10.1016/j.tips.2011.06.008. Epub 2011 Sep 17.
10
Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.μ 阿片受体的功能选择性:对理解阿片类镇痛药和耐受的意义。
Pharmacol Rev. 2011 Dec;63(4):1001-19. doi: 10.1124/pr.111.004598. Epub 2011 Aug 26.